Want to join the conversation?
$QGEN said no meaningful revenue contribution from GeneReader NGS System were included in its 2016 financial forecasts. Company also does not expect a material impact from the court's decision on its full-year 2016 outlook nor anticipates any material changes to its internal 2017 projections. A trial date in the case is scheduled for Nov. 2017.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.